Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ali Nazarizadeh has a total of 44 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Facile and High-Throughput Immobilization Method for Fractionated Radiotherapy of Unanesthetized Mice Bearing Subcutaneous Tumors Using a 6 MV LINAC Clinical Facility

    by Ali Nazarizadeh, Quy Van-Chanh Le, Wendy Phillips, Tyron Turnbull, Hien Le, Chris Brown, Ivan Kempson

    Anesthesia is the gold standard for immobilization of tumor-bearing mice before radiotherapy which potentially induces stress and distorts disease progression. Irradiation of preclinical cancer models with clinical MV linear accelerator (LINAC) beams can benefit the translation of new strategies in radiation oncology. However, logistical constraints prohibit widespread use of clinical facilities. Currently, there is no detailed protocol on how to safely introduce mice to a clinical environment to be intervened on using hospital equipment. Here, a facile and high-throughput handling method is described that eliminates anesthesia and enables fractionated radiotherapy of multiple mice simultaneously for high-throughput studies. Subcutaneous breast tumor-bearing BALB/c mice were restrained in plastic restraint cones within a containment tray and received four fractions of 4 Gy X-rays from a 6 MV LINAC source over two weeks (two fractions/week). Both short- and long-term follow-up revealed no identifiable health issues or complications associated with the restraint procedure or radiation exposure in terms of body weight loss, skin burns or body condition scores. This method not only benefits animal welfare but also data quality by reducing stress/discomfort levels and confounding effects of anesthetics. It can be applied to a broader range of studies where mice need to be immobilized before intervention.

  • Open Access

    Aluminium Nanoparticles as Efficient Adjuvants Compared to Their Microparticle Counterparts: Current Progress and Perspectives

    by Ali Nazarizadeh, Alexander H. Staudacher, Nicole L. Wittwer, Tyron Turnbull, Michael P. Brown, Ivan Kempson

    Aluminium (Al) compounds are used as adjuvants in human and veterinary prophylactic vaccines due to their improved tolerability compared to other adjuvants. These Al-based adjuvants form microparticles (MPs) of heterogeneous sizes ranging from ~0.5 to 10 µm and generally induce type 2 (Th2)-biased immune responses. However, recent literature indicates that moving from micron dimension particles toward the nanoscale can modify the adjuvanticity of Al towards type 1 (Th1) responses, which can potentially be exploited for the development of vaccines for which Th1 immunity is crucial. Specifically, in the context of cancer treatments, Al nanoparticles (Al-NPs) can induce a more balanced (Th1/Th2), robust, and durable immune response associated with an increased number of cytotoxic T cells compared to Al-MPs, which are more favourable for stimulating an oncolytic response. In this review, we compare the adjuvant properties of Al-NPs to those of Al-MPs in the context of infectious disease vaccines and cancer immunotherapy and provide perspectives for future research.


  • Open Access

    MicroRNA-154: A Novel Candidate for Diagnosis and Therapy of Human Cancers

    by Ali Nazarizadeh, Forogh Mohammadi, Fatemeh Alian, Parisa Faraji, Mitra Nourbakhsh, Shahin Alizadeh-Fanalou

    MicroRNAs (miRNAs) are endogenous, non-coding, single-stranded, tiny RNAs with 21– 23 nucleotides that regulate several biological functions through binding to target mRNAs and modulating gene expression at post-transcriptional levels. Recent studies have described crucial roles for miRNAs in pathophysiology of numerous human cancers. They can act as an oncogene and promote cancer or as a tumor suppressor and alleviate the disease. Recently discovered microRNA-154 (miR-154) has been proposed to be involved in multiple physiological and pathological processes including cancer. With this aspect, aberrant expression of miR-154 has been demonstrated in variety of human malignancies, suggesting an important role for miR-154 in tumorigenesis. To be specific, it is considered as a tumor suppressor miRNA and exerts its beneficial effects by targeting several genes. This review systematically summarizes the recent advances done on the role of miR-154 in different cancers and discusses its potential prognostic, diagnostic and therapeutic values.


  • Effects of Securigera Securidaca seed extract in combination with glibenclamide on antioxidant capacity, fibroblast growth factor 21 and insulin resistance in hyperglycemic rats

    by Shahin Alizadeh-Fanalou, Mohammad Babaei, Asieh Hosseini, Namamali Azadi, Ali Nazarizadeh, Asie Shojaii, Mohammad Borji, Hassan Malekinejad, Elham Bahreini


  • Open Access

    Effects of Securigera securidaca (L.) Degen & Dorfl seed extract combined with glibenclamide on paraoxonase1 activity, lipid profile and peroxidation, and cardiovascular risk indices in diabetic rats

    by Shahin Alizadeh-Fanalou, Ali Nazarizadeh, Mohammad Babaei, Mohsen Khosravi, Navid Farahmandian, Elham Bahreini

    Introduction: Seeds of Securigera securidaca (L.) Degen & Dorfl are rich in flavonoids and phenolic acids which have potent biological effects. The current study was undertaken to evaluate the effects of hydroalcoholic extract of S. securidaca seeds (HESS) alone, and in combination with a standard drug, glibenclamide (GB) on paraoxonase1 (PON1) activity, lipid profile and peroxidation, and cardiovascular risk indices in streptozotocin (STZ) induced diabetic rats. Methods: Forty-eight male Wistar rats were randomly divided into eight equal groups and orally treated with various doses of HESS (100, 200, 400 mg/kg) alone and in combination with GB (5 mg/kg) for 35 consecutive days. After blood sampling, lipid profile including triglyceride (TG), cholesterol, high, low and very low-density lipoprotein-cholesterol (HDL-C, LDL-C, and VLDL-C), as well as serum PON1 activity, were assessed. Malondialdehyde (MDA), tumor necrosis factor-alpha (TNF-α), and high-sensitivity C-reactive protein (hs-CRP) levels were also measured. Several indices of cardiovascular risk and the correlation between PON1 activity and these indices were calculated based on the obtained results from the lipid profile. Results: Induction of diabetes could dramatically alter all of the parameters mentioned above, and the lower dose of HESS (100 mg/kg) was not effective in restoring the parameters. However, the higher doses (200 and 400 mg/kg) alone and in combination with GB could significantly improve lipid profile, restore PON1 activity, and decrease cardiovascular risk indices, MDA, as well. However, neither HESS nor GB could significantly reduce TNF-α and hs-CRP. A significant negative correlation also was detected between PON1 activity and cardiovascular risk indices. Conclusion: conclusively, HESS can be considered as a potent antihyperlipidemic agent with remarkable cardioprotective effects and can potentiate the antidiabetic effects of GB.


  • Open Access

    Selenium supplementation in the form of selenium nanoparticles and selenite sodium improves mature male mice reproductive performances

    by Siamak Asri-Rezaei, Alireza Nourian, Ali Shalizar-Jalali, Golamreza Najafi, Ali Nazarizadeh, Mobin Koohestani, Ali Karimi

    Objective(s): The current study was conducted to examine the possible protective and retentive effects of one-week intra-peritoneal (IP) administration of selenium nanoparticles (Se-NPs), compared to its bulk counterpart, selenite sodium (Ss), after one complete cycle of spermatogenesis in mature male mice. Materials and Methods: Thirty adult male mice were divided into 3 groups. Control group was administrated phosphate-buffered saline (IP) and the other groups received Ss (0.50 mg kg-1) and Se-NPs (0.50 mg kg-1) for seven successive days. Then, the animals were monitored for 28 days and finally sacrificed and tissue and blood samples were taken. Histopathological features, sperm quality, in vitro fertilization (IVF) capability and selenium (Se) content in testicular tissue were analyzed. Antioxidant enzyme activities including catalase, glutathione peroxidase, and superoxide dismutase as well as total antioxidant capacity and malondialdehyde levels were assessed in blood and the tissue samples. Results: Remarkable differences were found in sperm characteristics, histopathological features and oxidative stress biomarkers between control and treatment groups. Moreover, IVF evaluation and tissue Se concentration examination weren't similar for Se-NPs and Ss. Conclusion: Conclusively, Se-treated groups had more antioxidant capacity than the control group, but sperm quality and histopathological features revealed that Se-NPs might possess more antioxidative and retentive potential compared to Ss in one spermatogenesis cycle.


  • Comparative study of radioprotective effects of selenium nanoparticles and sodium selenite in irradiation-induced nephropathy of mice model

    by Masoumeh Karami, Siamak Asri-Rezaei, Banafshe Dormanesh, Ali Nazarizadeh

    The current study was undertaken to evaluate radioprotective effects of selenium (Se) nanoparticles in irradiation-induced nephropathy of mice model compared to sodium selenite. Forty-five mice were divided into three major groups including control, Se nanoparticle, and sodium selenite. Each major group was further subdivided into three more groups receiving various doses of 0, 2, and 8 Gy gamma irradiation. Both of the supplements were administered intraperitoneally with the dose of 0.1 mg/kg for 14 consecutive days. At the end of each week, the animals were exposed to gamma radiation and 48 h after the last exposure, the animals were humanely euthanized, then blood and renal tissue samples were taken. Serum creatinine, urea, cystatin C, and beta-2-microglobulin levels as well as activities of renal antioxidant enzymes, superoxide dismutase, glutathione peroxidase and catalase, also malondialdehyde level, total antioxidant capacity, renal tissue Se content, and histopathological features were assessed. The results showed that both of the supplements could normalize aforementioned indices. However, selenium nanoparticles (Se-NPs) were more effective than sodium selenite. Conclusively, Se-NPs as an emerging potent antioxidant agent can protect against irradiation-induced nephropathy.


  • Open Access

    Anthelmintic effects of zinc oxide and iron oxide nanoparticles against Toxocara vitulorum

    by Ruhollah Dorostkar, Majdedin Ghalavand, Ali Nazarizadeh, Mahdi Tat, Mohammad Sadegh Hashemzadeh


    • 12 January 2016
      • Vol. 10  (5) , 429-435
    Open Access

    Hydro-alcoholic extract of Raphanus sativus L. var niger attenuates bleomycin-induced pulmonary fibrosis via decreasing transforming growth factor β1 level

    by Mohammad Hossein Asghari, Rahim Hobbenaghi, Ali Nazarizadeh, Peyman Mikaili

    Pulmonary fibrosis is a progressive disease of the lungs, which leads to death in human. It has been suggested that transforming growth factor beta 1 (TGF-β1) together with oxidative stress play a central role in the pathogenesis of the ailment. The objective of this study was to evaluate the possible curative effects of black radish, Raphanus sativus L. var niger (RSN) on bleomycine (BLM) -induced pulmonary fibrosis in a rat model. In this study, thirty-six male Wistar rats were divided into six groups, including: (I) positive (BLM) control group, (II) negative (normal saline) control group, (III) sham group (R. sativus extract 150 mg/kg), and (IV-VI) treatment groups. In order to induce pulmonary fibrosis, four groups were treated with a single dose of BLM sulfate (7.5 U/kg) through intratracheal instillation. Treatment groups (IV-VI) received RSN extract (75, 150, and 300 mg/kg) orally a week before and two weeks after the administration of BLM. At the end of the treatment course, blood and lung tissue samples were taken and the measurement of TGF-β1 and histopathological examination of the lung tissues performed. The results showed that RSN, at 300 mg/kg dose, could significantly decrease the serum level of TGF-β1 and severity of the histological lesions as compared to the positive control group. The results of the current study indicate that the components present in the extract can remarkably prevent the aggravation of pulmonary fibrosis via decreasing TGF-β1 level.